Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Evome Medical Technologies Inc V.EVMT

Alternate Symbol(s):  LNDZF

Evome Medical Technologies Inc. is an international medical device company, which is focused on human performance and rehabilitative solutions. The Company’s products include Biodex Rehab product, Damar Plastics product, Mio-Guard product, Simbex services, and SDP product. Its Biodex Rehab products include Isokinetic Systems, Gait Trainer, Body-Weight Supported Training, Cycles and Ergometers, and Squat-Assist Trainer. Its Mio-Guard products include bags, cases and kits, braces, and supports, diagnostics and instruments, furniture, and equipment, padding and splinting, personal protection, sanitizers and disinfectants, and tapes and wraps. Its applications include fall risk screening and conditioning, patient-driven payment model (PDPM), wellness, sports medicine solutions, neurological involvement, safe patient handling and mobility, and senior living and rehabilitation. It offers concussion, fall screening and balance assessment and training programs.


TSXV:EVMT - Post by User

Comment by excitingon Jun 03, 2016 7:54am
98 Views
Post# 24930408

RE:Odd

RE:OddYou are a long contributor in SH and i respect your view. Maybe there are red flags as you pointed out but up to now the company is delivering what it said. The 1st Qtr should give us a more clearer picture. I do think LND will continue to grow cause the business is sound and the risk is rather low. My question is they can keep the same pace of growth in the future. Probably yes and then they need credit to support that growth. Here comes RBP which is a superb fit to bring in that needed cash flow. So to say the sp will go down to 0.30$ to 0.45$ is indeed more than exagerated. I would be surprise if it go down to 0.50$ ever again. LND is a venture company and is of course a risk binding company but is derisking more and more overtime. Don`t forget we are making money. RBP is probably a startup company as LND was 18 months ago but it fits perfectly in the growth strategy. This acquisition is lot better than just diluting the equity with a low SP. Time will tell if it would become a success story. Again i do think so cause LND knows and understand their potential customers. GLTA
Bullboard Posts